Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche Medical Dialogues Bureau25 Nov 2019 3:30 AM GMTMedian overall survival for patients with unresectable hepatocellular carcinoma (HCC), or that which cannot be surgically removed, getting Tecentriq...
Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC Medical Dialogues Bureau22 Oct 2019 4:20 AM GMTRoche, in its recent release, in 2018, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for Tecentriq in...
Eli Lilly gets USFDA nod for Cyramza to treat hepatocellular carcinoma Medical Dialogues Bureau14 May 2019 4:17 AM GMTThe USFDA has removed the boxed warning from the CYRAMZA labelling which highlighted warnings pertaining to haemorrhage, gastrointestinal perforation...
Singapore institutes collaborate with Samsung Medical Center to improve treatment of liver cancer Ruby Khatun Khatun16 Dec 2017 4:45 AM GMTSINGAPORE: Scientists and doctors from Singapore institutes are collaborating with Samsung Medical Center (SMC), a leading academic medical center in...
Exelixis drug improves overall survival in liver cancer patients Ruby Khatun Khatun21 Oct 2017 3:42 AM GMTExelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert...
